Advertisement

Topics

Adimab, Inc. Company Profile

23:12 EST 24th November 2017 | BioPortfolio

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements. For more information, visit http://www.adimab.com.


News Articles [6 Associated News Articles listed on BioPortfolio]

Eli Lilly licenses Adimab antibody discovery and optimization tech

Adimab, LLC is transferring its proprietary antibody discovery and optimization platform to Lilly research sites in San Diego and New York.

Adimab Announces Platform Transfer with Lilly

Brings Global Number of Research Sites Utilizing the Adimab Platform to Seven Adimab, LLC, a global leader in the discovery and optimization of fully human monoclonal a...

Adimab grants Lilly rights to antibody discovery platform

Adimab LLC. Announces Platform Transfer With Eli Lilly

  Life Sciences Jobs   ...

Adimab Announces Platform Transfer with Eli Lilly

NewsThis technology transfer expands an ongoing collaboration between the two companies that was initiated in 2010.

Adimab LLC Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAdimab LLC Adimab is an antibody discovery technology provider that offers antibody discovery and optimization platform. The company discovers antibodies for a range of disease areas including ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Adimab, Inc.

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental adva...

Adimab LLC

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental adva...

Adimab, LLC

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental adva...

Alector LLC

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer’s disease, ...

More Information about "Adimab, Inc." on BioPortfolio

We have published hundreds of Adimab, Inc. news stories on BioPortfolio along with dozens of Adimab, Inc. Clinical Trials and PubMed Articles about Adimab, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adimab, Inc. Companies in our database. You can also find out about relevant Adimab, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record